AIDA expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62525548574877E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.15785159238158E-12 |
Normal-vs-Stage2 |
4.49150000000342E-05 |
Normal-vs-Stage3 |
4.91384710699094E-13 |
Normal-vs-Stage4 |
1.6627810239811E-12 |
Stage1-vs-Stage2 |
3.075400E-01 |
Stage1-vs-Stage3 |
2.539200E-01 |
Stage1-vs-Stage4 |
7.819600E-02 |
Stage2-vs-Stage3 |
6.327000E-01 |
Stage2-vs-Stage4 |
8.195000E-01 |
Stage3-vs-Stage4 |
6.140400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
<1E-12 |
Normal-vs-AfricanAmerican |
6.556000E-03 |
Normal-vs-Asian |
2.766000E-02 |
Caucasian-vs-AfricanAmerican |
3.9311999999736E-07 |
Caucasian-vs-Asian |
3.358200E-01 |
AfricanAmerican-vs-Asian |
4.200800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.10782519111308E-15 |
Normal-vs-Female |
4.19442258703384E-13 |
Male-vs-Female |
9.223800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.38600000004963E-06 |
Normal-vs-Age(41-60Yrs) |
2.31148433726958E-12 |
Normal-vs-Age(61-80Yrs) |
5.44009282066327E-15 |
Normal-vs-Age(81-100Yrs) |
1.26410000023114E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.936000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.241800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.504800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.260000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.418200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.811200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.70589999999904E-05 |
Normal-vs-Grade 2 |
1.67665881178891E-12 |
Normal-vs-Grade 3 |
1.9515500326861E-12 |
Normal-vs-Grade 4 |
8.62210303154143E-12 |
Grade 1-vs-Grade 2 |
6.305800E-01 |
Grade 1-vs-Grade 3 |
8.811200E-01 |
Grade 1-vs-Grade 4 |
6.511200E-01 |
Grade 2-vs-Grade 3 |
2.080200E-01 |
Grade 2-vs-Grade 4 |
9.049000E-01 |
Grade 3-vs-Grade 4 |
1.956580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.6242562850266E-12 |
Normal-vs-ccB subtype |
4.53370000430553E-08 |
ccA subtype-vs-ccB subtype |
1.69507999999707E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.85007564823536E-12 |
Normal-vs-N1 |
1.4964000039086E-08 |
N0-vs-N1 |
1.987250E-01 |
|
|